Cytopathic effect inhibition assay for determining the in-vitro susceptibility of herpes simplex virus to antiviral agents

被引:29
作者
Cotarelo, M
Catalán, P [1 ]
Sánchez-Carrillo, C
Menasalvas, A
Cercenado, E
Tenorio, A
Bouza, E
机构
[1] Univ Gregorio Maranon, Gen Hosp, Serv Microbiol Clin & Enfermedades Infect VIH, Madrid 28007, Spain
[2] Ctr Nacl Microbiol Virol & Immunol Sanitarias, Inst Salud Carlos III, Madrid, Spain
关键词
D O I
10.1093/jac/44.5.705
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We compare a rapid dilution method for the determination of antiviral susceptibility of herpes simplex virus (HSV) with the plaque reduction assay, A total of 84 HSV clinical isolates were studied by both methods to detect in-vitro resistance to acyclovir and foscarnet, The rapid method showed for the detection of HSV isolates resistant to acyclovir and foscarnet, a sensitivity of 96.8% and 100% and specificity of 100% and 100%, respectively. This method provides an easy and accurate screening procedure for the susceptibility testing of HSV to antiviral agents.
引用
收藏
页码:705 / 708
页数:4
相关论文
共 9 条
[1]  
Arvin Ann M., 1995, P876
[2]   RESISTANCE OF HERPESVIRUSES TO ANTIVIRAL DRUGS [J].
CHATIS, PA ;
CRUMPACKER, CS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (08) :1589-1595
[3]   HERPES-SIMPLEX VIRUS RESISTANT TO ACYCLOVIR - A STUDY IN A TERTIARY CARE CENTER [J].
ENGLUND, JA ;
ZIMMERMAN, ME ;
SWIERKOSZ, EM ;
GOODMAN, JL ;
SCHOLL, DR ;
BALFOUR, HH .
ANNALS OF INTERNAL MEDICINE, 1990, 112 (06) :416-422
[4]   ACYCLOVIR-RESISTANT HERPES-SIMPLEX VIRUS-INFECTIONS IN PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
ERLICH, KS ;
MILLS, J ;
CHATIS, P ;
MERTZ, GJ ;
BUSCH, DF ;
FOLLANSBEE, SE ;
GRANT, RM ;
CRUMPACKER, CS .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (05) :293-296
[5]  
FIELD AK, 1994, CLIN MICROBIOL REV, V7, P1
[6]  
HIRSCH MS, 1995, MANDELL DOUGLAS BENN, P1336
[7]   CORRELATION BETWEEN RESPONSE TO ACYCLOVIR AND FOSCARNET THERAPY AND IN-VITRO SUSCEPTIBILITY RESULT FOR ISOLATES OF HERPES-SIMPLEX VIRUS FROM HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS [J].
SAFRIN, S ;
ELBEIK, T ;
PHAN, LH ;
ROBINSON, D ;
RUSH, J ;
ELBAGGARI, A ;
MILLS, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (06) :1246-1250
[8]  
SWEIRKOSZ EM, 1994, CLIN MICROBIOLOGY PR
[9]  
SWEIRKOSZ EM, 1995, MANUAL CLIN MICROBIO, P1415